Scientists at the University of Queensland in Brisbane, Australia, created a rapid vaccine production platform that can be adapted to make various vaccines. The platform uses a new technology called a “molecular clamp,” which helps stabilize viral surface proteins the vaccines use to prevent infections.
Scientists predict the platform could produce hundreds of thousands of vaccine doses ready for testing in as little as 16 weeks. The technology opens the door for the world to quickly respond to new and unknown pathogens.
Launched in 2017, CEPI is an alliance of public, private, philanthropic and civil organizations that aims to advance vaccine development to prevent future epidemics.
More articles on clinical leadership and infection control:
Infectious disease expert: Public health always suffers with political instability
Prescribed opioids raise patients’ pneumonia risk
Flu hospitalizations exceed 1K in Colorado
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
